GALNT3
Polypeptide N-acetylgalactosaminyltransferase 3
You are using an outdated browser. Please upgrade your browser to improve your experience.
Most Knowledge About | Knowledge Value
(0 to 1 scale) | ||
---|---|---|---|
PubMedID | 0.96 | ||
kinase perturbation | 0.81 | ||
histone modification site profile | 0.8 | ||
cellular component | 0.72 | ||
gene perturbation | 0.7 | ||
These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
- OR - satisfy the following criterion:
Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions
Target has at least one approved drug - AND - satisfies the preceding conditions
Click on a row in the table to change the structure displayed.
Data Source | Name | Explore in Pharos | Explore in Source | ||
---|---|---|---|---|---|
Reactome | Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC) | ||||
Reactome | Disease | ||||
Reactome | Diseases associated with O-glycosylation of proteins | ||||
Reactome | Diseases of glycosylation | ||||
Reactome | FGFR3 ligand binding and activation | ||||
Name | Explore in Pharos | Explore in Source | ||
---|---|---|---|---|
Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC) | ||||
Disease | ||||
Diseases associated with O-glycosylation of proteins | ||||
Diseases of glycosylation | ||||
FGFR3 ligand binding and activation | ||||
GO Term | Evidence | Assigned by | ||
---|---|---|---|---|
Inferred from Direct Assay (IDA) | BHF-UCL | |||
Inferred from Direct Assay (IDA) | BHF-UCL | |||
Inferred from Direct Assay (IDA) | BHF-UCL | |||
Inferred from Electronic Annotation (IEA) | UniProtKB-KW | |||
GWAS Trait | EFO ID | Study Count | SNP Count | Beta Count | Odds Ratio | Evidence (Mean Rank Score) | Provenance | ||
---|---|---|---|---|---|---|---|---|---|
bone density | 8 | 7 | 10 | 94.9 | |||||
1 | 1 | 1 | 52.4 | ||||||
intelligence | 2 | 2 | 1 | 6 | 34.9 | ||||
femoral neck bone mineral density | 1 | 1 | 1 | 14 | |||||
alkaline phosphatase measurement | 1 | 1 | 0 | 7 | 12 | ||||
GWAS Trait | EFO ID | Beta Count | Odds Ratio | Evidence (Mean Rank Score) | Provenance | ||
---|---|---|---|---|---|---|---|
bone density | 10 | 94.9 | |||||
1 | 52.4 | ||||||
intelligence | 1 | 6 | 34.9 | ||||
femoral neck bone mineral density | 1 | 14 | |||||
alkaline phosphatase measurement | 0 | 7 | 12 | ||||
Species | Name | Source ID | Gene ID | OMA | EggNOG | Inparanoid | ||
---|---|---|---|---|---|---|---|---|
Chimp | polypeptide N-acetylgalactosaminyltransferase 3 | VGNC:10819 | 459702 | |||||
Macaque | polypeptide N-acetylgalactosaminyltransferase 3 | 707605 | ||||||
Mouse | MGI:894695 | 14425 | ||||||
Rat | RGD:1306443 | 366061 | ||||||
Dog | polypeptide N-acetylgalactosaminyltransferase 3 | VGNC:41095 | 478774 | |||||
Species | Name | OMA | EggNOG | Inparanoid | ||
---|---|---|---|---|---|---|
Chimp | polypeptide N-acetylgalactosaminyltransferase 3 | |||||
Macaque | polypeptide N-acetylgalactosaminyltransferase 3 | |||||
Mouse | ||||||
Rat | ||||||
Dog | polypeptide N-acetylgalactosaminyltransferase 3 | |||||
PMID | Year | Title |
---|